Business
MjMicro Finalizes Presenter Schedule for June 25 Investor Conference in NYC
MjMicro Finalizes Presenter Schedule for June 25 Investor Conference in NYC.
About this update from Decentral Life, Inc.
[{"type":"text","content":"\nNEW YORK, June 06, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – MjMicro Conference (www.mjmicro.com), the next-level investor forum for publicly traded cannabis companies, has published the final presenter schedule for its upcoming investor conference, which will take place June 25, 2019, at the Westin Grand Central in New York City.\n The MjMicro Conference is an invitational networking forum, and this one-day conference provides an exceptional opportunity for private capital investors to connect with cannabis-related public entities and for attendees to hear from industry experts. During the conference, Emerald Health Therapeutics, FSD Pharma, and Helix TCS will host spotlight presentations before the general audience. Emerald Health Therapeutics, Inc. is a Canada-based, Health Canada-licensed medical cannabis producer. Through its subsidiary, Emerald is engaged in the production and sale of medical marijuana and also has interest in a company that produces, cultivates and distributes wholesale cannabis and cannabis extracts for therapeutic and non-therapeutic use purposes. The company offers Emerald Health Botanicals products in pill or capsule formats. FSD Pharma, through its wholly owned subsidiary FV Pharma Inc., is focused on developing the highest-quality indoor-grown, pharmaceutical-grade cannabis and on research and development of novel cannabinoid-based treatments for several central nervous system disorders, including chronic pain, fibromyalgia and irritable bowel syndrome. FSD has 25,000 square feet of cultivation space that is licensed at its Ontario facility, with expansion currently underway. Helix TCS, Inc. is the leading provider of critical infrastructure services for the legal cannabis industry, helping owners and operators of licensed cannabis businesses stay competitive and compliant while mitigating risk in an ever-changing and expanding market. Through its wholly owned subsidiaries BioTrackTHC, Cannabase, and Helix Security, Helix TCS offers products that reach over 2,000 licensed locations in 36 states and six countries and have tracked over $18 billion in legal cannabis sales. Feature presentations at MjMicro Conference, following a hosted lunch, will be given by 1933 Industries, 48North Cannabis, CannAmerica Brands, Cannex Capital Holdings/4Front, Cardiol Therapeutics, Dixie Brands, EXMceuticals,...